Procept (PRCT): Enterprise Value to EBITDA Ratio
PROCEPT BioRobotics is recognized as a leader in urological robotics, as evidenced by the evolution of its EV/EBITDA multiple over time. This trend is driven by the expansion of the AquaBeam system, which is displacing laser-based methods. However, risks remain regarding shrinking hospital budgets and insurance coverage. The value of 0.00 determines the latest business valuation metric relative to operating profit, adjusted for debt.
Comprehensive metric breakdowns and analytics for procept-biorobotics.com (PRCT)
- stock price and consensus target price:
- stock exchange capitalization data:
- business book valuation details:
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio PROCEPT BioRobotics|PRCT - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity PROCEPT BioRobotics Corporation|PRCT - Company Total Debt|Debts to Book Capitalization Procept|PRCT - Long-Term Debt|Company Short-Term Debts PROCEPT BioRobotics|Quick Ratio procept-biorobotics.com
- financial results and valuation multiples details:
PRCT - Net Financial Result|Projected Future Earnings PROCEPT BioRobotics|PRCT - Price to Earnings Ratio|Forward P/E Multiple PROCEPT BioRobotics|PRCT - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Procept|PRCT - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months PROCEPT BioRobotics|PRCT - Earnings per share for the trailing year|Quarterly EPS earnings growth procept-biorobotics.com|PRCT - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year PROCEPT BioRobotics
Analysis of all company metrics:PROCEPT BioRobotics Inc PRCT
For PROCEPT BioRobotics, which is scaling the innovative Aquablation robotic surgery standard, aligning the total enterprise value with operational efficiency is critical. By analyzing the company's dynamic EV/EBITDA ratio, an investor assesses total capital and debt relative to earnings before interest, taxes, depreciation, and amortization, enabling the timely identification of market imbalances and the determination of the fundamental bottom during a period of structural growth.
Competitor analysis
Dexcom Corp - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Penumbra Medical PEN|NOVT: Enterprise Value to EBITDA Ratio|haemonetics.com - Enterprise Value to Operating Income Before Depreciation Ratio|INSP: EV/EBITDA Multiple|CNMD - Total Company Value to Operating Income Before Depreciation Ratio|PLSE (Pulse Corp) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio InMode MD (INMD)|Enterprise Value to EBITDA Ratio PMI (Picard Medical Inc)|SRDX (surmodics.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Senseonics Holdings Inc SENS|NPCE - Enterprise Value to EBITDA Ratio|Tactile Systems Technology Inc. - EV/EBITDA Multiple|Company Value to EBITDA SANUWAVE Health Inc|OM: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation ELMD|LNSR (LENSAR) - EV/EBITDA Multiple|AVITA Medical Inc. (RCEL) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple PROF|Enterprise Value to EBITDA Ratio bairdmed.com BDMD|EV/EBITDA Multiple EDAP (EDAP TMS)|EV/EBITDA Multiple Apyx Medical Corp APYX|ICCM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|LUNG: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TELA (telabio.com) - Enterprise Value to EBITDA Ratio|CytoSorbents Corporation - Business Value to Operating Income Before Depreciation|SRTS (Sensus Healthcare, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA zynex.com ZYXI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization electroCore, Inc. (ECOR)|vicarioussurgical.com (RBOT) - Enterprise Value to EBITDA Multiple|Inspira Technologies - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple SeaStar Medical Holding Corp. ICU|IRIDEX Corp. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Intelligent Bio Solutions INBS|beyondair.net (XAIR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio PFSA (Profusa Inc.)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization STRATA Skin Sciences Inc.|Enterprise Value to EBITDA Ratio GlucoTrack Inc. (GCTK)|EV/EBITDA Multiple NAOV|VERO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nuwellis NUWE|AEMD: Enterprise Value to Operating Income Before Depreciation|ASXC: Enterprise Value to EBITDA Ratio|Avinger Inc - Enterprise Value to Operating Income Before Depreciation Ratio|BioSig Technologies, Inc. (BSGM) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio CUTR (cutera.com)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Know Labs|NARI: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nevro Corporation (NVRO)|RSLS - Company Value to EBITDA|EV/EBITDA Multiple SILK (Silk Road Medical, Inc)
